Revenue for the full year to 31 December 2012 was at pound 3.3bn, a 2% rise, while underlying pre-tax profit was up 1% to pound 418bn.
Graham Chipchase (pictured), Rexam’s chief executive, said: “”In 2012, we made further encouraging progress. Beverage Cans traded well driven by the global growth in specialty cans and a strong recovery in our market share in the US.
“We saw good growth in all our regions with volumes up 6% and organic operating profit increasing by 5%. We are continuing to invest in new lines and capacity to support our future growth. However, as previously highlighted, Healthcare had a difficult year largely due to one of our customer’s products coming off patent.”
Chipchase added that the sale of Rexam’s personal care business made pound 395m, a sum that is being returned to shareholders.
He said: “We expect to make further progress in 2013 despite an uncertain macroeconomic environment and continued cost pressures. Further contractual gains in North America and continued growth in our European and South American beverage can businesses give us confidence we will achieve our 15% ROCE target.”
